Publication Ethics and Malpractice
About Ethics and Malpractice
The Indo American Journal of Pharmaceutical Research (IAJPR) adheres to the highest standards of publication ethics, guided by best practices from COPE (Committee on Publication Ethics) and Elsevier's PERK (Publisher Ethics Resource Kit).
Publication Frequency
About Frequency
IAJPR is a monthly journal, publishing twelve issues annually. The publication of articles in peer-reviewed journals is a critical element in building a respected and coherent body of scientific knowledge. It reflects both the quality of the authors' work and the support provided by their institutions.
Complaints
About Complaints
Any concerns regarding published material should be directed to the Editor-in-Chief.

Duties of Authors

  • Reporting Standards: Authors must present an accurate and objective account of their research and its significance. All underlying data should be accurately represented in the manuscript, with appropriate references provided to enable verification of sources. Fraudulent or knowingly inaccurate statements are considered unethical and unacceptable.
  • Originality and Plagiarism: Authors must ensure that their work is entirely original and appropriately cites or quotes any prior work. Plagiarism in any form is considered unethical and unacceptable.
  • Multiple or Concurrent Publication: Authors should avoid publishing manuscripts describing the same research in multiple journals. Concurrent submission of the same manuscript to more than one journal is considered unethical. However, secondary publication may be justified under specific conditions, provided that it reflects the same data and interpretation as the primary document, with appropriate citation of the original work.
  • Acknowledgement of Sources: Proper acknowledgment of others' contributions must be given according to bibliographic standards. Privately obtained information, such as from conversations or confidential services, must not be used without explicit permission. This includes data from refereeing manuscripts or grant applications.
  • Authorship: All significant contributors to the research should be listed as co-authors. Those who do not meet the criteria for authorship should be acknowledged in the manuscript.
  • Appeal Against Editorial Decision: Authors have the right to appeal any editorial decision. Appeals should be directed to the Editor-in-Chief with a detailed rebuttal.

Duties of Editors

  • Quality Assurance: Editors are responsible for ensuring the quality of each publication. Decisions to accept or reject manuscripts should be based solely on their importance, originality, clarity, and relevance to the field of pharmaceutical research.
  • Publication Decisions: Editors decide which articles to publish based on established policies and the work's significance to researchers and readers.
  • Peer Review: All submitted manuscripts undergo a rigorous peer-review process to ensure high scientific quality. The peer review is a key aspect of maintaining the journal's standards.
  • Fair Play: Manuscripts are evaluated based on intellectual content, without regard to the author's race, gender, sexual orientation, religious beliefs, ethnicity, citizenship, or political views.
  • Confidentiality: Editors must ensure that all submitted materials remain confidential during the review process.
  • Conflicts of Interest: Editors must make unbiased decisions, free from commercial influences, and should recuse themselves from reviewing manuscripts where they have a conflict of interest. They must also consider any potential conflicts when selecting reviewers.
  • Unethical Publishing: Editors will address ethical complaints and questionable publishing behavior by investigating and taking appropriate actions, even if issues are identified years after publication.

Duties of Reviewers

  • Contribution to Editorial Decisions: Peer review supports editorial decisions and helps authors improve their manuscripts. It is central to scholarly communication and the scientific method.
  • Promptness: Reviewers who are unqualified or unable to review a manuscript promptly should notify the editor and withdraw from the review process.
  • Disclosure and Conflict of Interest: Reviewers must not use unpublished materials from manuscripts in their own research without explicit written consent. Confidential information obtained during the review must not be used for personal gain. Reviewers should also avoid reviewing manuscripts where they have a conflict of interest.
  • Confidentiality: Manuscripts must be treated as confidential documents and should not be shared or discussed outside the review process.
  • Standards of Objectivity: Reviews should be objective and free from personal criticism. Reviewers should provide clear, well-supported evaluations.
  • Acknowledgement of Sources: Reviewers should identify relevant work that has not been cited by the authors and report any substantial similarities with other published work.
Sanctions
About Sanctions
In cases of documented violations of these policies, the following sanctions will be enforced:
  • Immediate rejection of the offending manuscript.
  • Immediate rejection of any additional manuscripts submitted by the authors of the infringing manuscript.
  • A prohibition on new submissions from the authors to any IAJPR journal for a minimum of 36 months.
  • A prohibition on serving on the Editorial Board of any IAJPR journal.
  • In cases of severe violations, additional sanctions may be applied beyond those outlined above.